Post‑operative Evaluation and Management of Metabolic Complications after Parathyroidectomy

Initial Metabolic Assessment

Obtain serum calcium (albumin‑corrected or ionized), intact PTH, phosphate, magnesium, and urinary calcium excretion to differentiate hypoparathyroidism from hungry‑bone syndrome. [@1]
Hungry‑bone syndrome is characterized by severe hypocalcemia (≤ 1.9 mmol/L), normal or elevated PTH, low phosphate, low magnesium, and low urinary calcium despite supplementation, and it can provoke autonomic symptoms such as sweating. [@2]
Hypoparathyroidism presents with hypocalcemia together with inappropriately low or normal PTH levels. [@3]
Permanent hypoparathyroidism is defined by persistent hypocalcemia for ≥ 12 months with low PTH on two measurements taken ≥ 2 weeks apart. [@4]
Patients with extensive pre‑operative skeletal disease (e.g., brown tumors) or marked vitamin D deficiency are at increased risk for hungry‑bone syndrome. [@2]

Measure TSH and free T4 to detect postoperative thyroid hormone imbalance; both hypothyroidism and overtreatment with levothyroxine can cause excessive sweating. [@4]
Target TSH range after benign thyroid disease is 0.3–4.1 mIU/L. [@4]
Levothyroxine dosing should be ≈ 1.6 µg/kg/day (ideal body weight) in young adults, with a 20–25 % dose reduction in elderly patients. [@4]

Maintain serum 25‑OH vitamin D above 30 ng/mL (75 nmol/L) to reduce the risk of postoperative metabolic complications. [@1]

Administer high‑dose 1‑α‑hydroxy vitamin D (calcitriol 0.5 µg daily initially, titrated as needed), intravenous calcium gluconate for severe cases, and oral calcium carbonate 1,250–2,500 mg four times daily (total elemental calcium 5–10 g/day). [@1]

Treat symptomatic hypocalcemia or calcium ≤ 1.9 mmol/L with elemental calcium 0.5–1 g daily after unilateral surgery or 1–3 g daily after bilateral or revision surgery. [@4]
Correct concurrent magnesium deficiency before or alongside calcium therapy, as hypomagnesemia impairs PTH secretion and calcium homeostasis. [@4]
Life‑threatening hypocalcemia (calcium < 7.5 mg/dL or < 1.9 mmol/L) requires an IV calcium gluconate bolus of 1 g over 10 min followed by continuous infusion with cardiac monitoring. [@4]

Measure serum calcium the day after surgery and at least once during the first postoperative week (earlier if symptoms develop). [@4]
Perform weekly calcium monitoring throughout the first postoperative month. [@1]
Schedule a formal postoperative visit 1–2 weeks after discharge to reassess calcium, PTH, and adjust supplementation. [@4]
At one year, obtain serum calcium, 25‑OH vitamin D, creatinine with eGFR, and urinary calcium; routine PTH measurement is not required unless hypocalcemia persists. [@1]

Excessive sweating is not a recognized direct complication of parathyroidectomy; alternative etiologies must be explored. [@5]
Potential non‑surgical causes include:
- Medication side effects. [@1]
- Infection or inflammatory processes. [@6]
- Other endocrine disorders (hyperthyroidism, pheochromocytoma, carcinoid syndrome). [@1]
- Autonomic dysfunction unrelated to surgery. [@3]
- Anxiety or psychological stress related to the operation. [@6]

Do not attribute postoperative sweating to the surgery without first excluding hypocalcemia and hungry‑bone syndrome, as these conditions can be life‑threatening if untreated. [@2]
Parathyroid function may recover even years after a diagnosis of permanent hypoparathyroidism; ongoing monitoring remains essential. [@3]
If persistent or recurrent hyperparathyroidism is suspected (hypercalcemia within 6 months or recurrence after 6 months), confirm the diagnosis and exclude secondary hyperparathyroidism and familial hypocalciuric hypercalcemia before considering revision surgery. [@5]